Precision NanoSystems specializes in the development of lipid nanoparticles (LNPs) for the delivery of genomic medicines, including mRNA vaccines and therapeutics. Their flagship technology, the NanoAssemblr® platform, utilizes proprietary microfluidic mixing technology to create high-quality, reproducible LNP formulations that can be scaled from laboratory to Good Manufacturing Practice (GMP) conditions. This platform is designed to facilitate the efficient production of lipid nanoparticles, which are essential for protecting nucleic acids and ensuring their safe delivery into target cells. The company offers a comprehensive lipid nanoparticle portfolio that includes off-the-shelf kits and custom formulations, enabling drug developers to rapidly progress from discovery to clinical evaluation.

The LNP technology developed by Precision NanoSystems is particularly notable for its use of ionizable cationic lipids, which play a critical role in the formulation process. These lipids can adapt their charge based on pH, enhancing the binding of nucleic acids while minimizing cytotoxicity. This modular approach allows for the optimization of LNP formulations tailored to specific therapeutic applications, such as gene therapy, cell therapy, and mRNA vaccines. By providing a robust toolkit for genomic medicine development, Precision NanoSystems aims to accelerate the transition of innovative therapies from preclinical stages to clinical trials, ultimately enhancing the efficacy and safety of nucleic acid-based treatments.

Canada

Precision NanoSystems, now part of Cytiva, is a global leader in ushering in the next wave of genomic medicines in infectious diseases, cancer, and rare diseases. We work with the world's leading drug developers to understand disease and create the therapeutics and vaccines that will define the future of medicine. PNI offers proprietary technology platforms and comprehensive expertise to enable researchers to translate disease biology insights into non-viral genomic medicines.

Infectious Diseases

50-50 - 655 WEST KENT AVE. N., VANCOUVER, British Columbia BC V6P 6T7, CA

Precision Nanosystems

Company Details